Mettler-Toledo International (NYSE:MTD) Research Coverage Started at Wolfe Research

Wolfe Research assumed coverage on shares of Mettler-Toledo International (NYSE:MTDFree Report) in a research note issued to investors on Friday. The brokerage issued a peer perform rating on the medical instruments supplier’s stock.

A number of other equities analysts also recently issued reports on MTD. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wells Fargo & Company dropped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Evercore ISI upped their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Finally, Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $1,351.25.

View Our Latest Stock Analysis on MTD

Mettler-Toledo International Trading Up 0.0 %

Shares of MTD stock opened at $1,276.98 on Friday. The firm has a fifty day simple moving average of $1,305.85 and a two-hundred day simple moving average of $1,376.41. Mettler-Toledo International has a 12 month low of $1,115.64 and a 12 month high of $1,546.93. The firm has a market capitalization of $26.95 billion, a PE ratio of 34.43, a price-to-earnings-growth ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. On average, equities analysts predict that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now directly owns 6 shares in the company, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently modified their holdings of MTD. Family Firm Inc. purchased a new position in Mettler-Toledo International in the 2nd quarter valued at approximately $25,000. Blue Trust Inc. boosted its holdings in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the period. Ashton Thomas Securities LLC bought a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at $37,000. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in Mettler-Toledo International in the 2nd quarter worth about $42,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.